Detail page

Knowledge Web

Person

Daniel Habermehl (1979-)

Arzt

Name	Daniel Habermehl
Time	1979- (Date of birth and death)
Place	Bad Schwalbach (Geburtsort) Deutschland
Gender	männlich
Academic degree	Dr. med. (an der Medizinischen Fakultät der Universität Tübingen) (2009)
Profession	Arzt (characteristic profession) Wissenschaftlicher Mitarbeiter
Variant	Daniel Frédéric Habermehl D. Habemehl
Related	Klinikum Heidelberg (bis circa 2014) Radiologische Klinik (Heidelberg) (bis circa 2014) Technische Universität München (ab circa 2014)
Further information	Habil.-Schr. an der Fakultät für Medizin (Fach Radioonkologie und Strahlentherapie) der TU München, 2015
Record type	Person
GND-Identifier	13804130X
Record ID	13804130X
Involved in show all Der Einfluss von Diabetes auf Effektivität und Toxizität der strahlentherapeutischen Behandlung von Tumoren des Gastrointestinaltrakts am Beispiel der Ösophagus- und Rektumkarzinome Analyse von Überlebenszeit und Prognosefaktoren bei Palliativpatienten mit metastasierenden Gastrointestinaltumoren : Erstellung eines Prognosescores & Retrospektive Analyse Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis Dosimetric comparison of different radiation techniques (IMRT vs. 3-dimensional) of the “true” (deep) ano-inguinal lymphatic drainage of anal cancer patients Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) – the ESMERALDA trial Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma Experimentelle und klinische Untersuchungen zur Evaluation der Effektivität und Sicherheit multimodaler radioonkologischer Therapiekonzepte und der Partikeltherapie zur Behandlung von Tumoren des Verdauungstraktes Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects Spinal bone metastases in gynecologic malignancies: a retrospective analysis of stability, prognostic factors and survival Palliative radiation therapy in patients with metastasized pancreatic cancer - description of a rare patient group Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy - first results of a randomized pilot trial Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial Single-dose radiosurgical treatment for hepatic metastases - therapeutic outcome of 138 treated lesions from a single institution Development and validation of automatic tools for interactive recurrence analysis in radiation therapy: optimization of treatment algorithms for locally advanced pancreatic cancer Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection Long term toxicity and prognostic factors of radiation therapy for secreting and non-secreting pituitary adenomas Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial Monitoring of patients treated with particle therapy using positron-emission-tomography (PET): the MIRANDA study Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial Identifizierung Apoptose-induzierender Alkaloide der Pflanze Chelidonium Majus und des Präparates Ukrain in einem Lymphom-Modell Identifizierung Apoptose-induzierender Alkaloide der Pflanze Chelidonium Majus und des Präparates Ukrain in einem Lymphom-Modell

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Daniel Habermehl (1979-)

Der Einfluss von Diabetes auf Effektivität und Toxizität der strahlentherapeutischen Behandlung von Tumoren des Gastrointestinaltrakts am Beispiel der Ösophagus- und Rektumkarzinome

Analyse von Überlebenszeit und Prognosefaktoren bei Palliativpatienten mit metastasierenden Gastrointestinaltumoren : Erstellung eines Prognosescores & Retrospektive Analyse

Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis

Dosimetric comparison of different radiation techniques (IMRT vs. 3-dimensional) of the “true” (deep) ano-inguinal lymphatic drainage of anal cancer patients

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma

Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning

First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas

Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) – the ESMERALDA trial

Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects

Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma

Experimentelle und klinische Untersuchungen zur Evaluation der Effektivität und Sicherheit multimodaler radioonkologischer Therapiekonzepte und der Partikeltherapie zur Behandlung von Tumoren des Verdauungstraktes

Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects

Spinal bone metastases in gynecologic malignancies: a retrospective analysis of stability, prognostic factors and survival

Palliative radiation therapy in patients with metastasized pancreatic cancer - description of a rare patient group

Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy - first results of a randomized pilot trial

Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial

Single-dose radiosurgical treatment for hepatic metastases - therapeutic outcome of 138 treated lesions from a single institution

Development and validation of automatic tools for interactive recurrence analysis in radiation therapy: optimization of treatment algorithms for locally advanced pancreatic cancer

Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response

Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection

Long term toxicity and prognostic factors of radiation therapy for secreting and non-secreting pituitary adenomas

Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma

Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework

Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial

Monitoring of patients treated with particle therapy using positron-emission-tomography (PET): the MIRANDA study

Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas

Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer

In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells

Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial

Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial

Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial

Identifizierung Apoptose-induzierender Alkaloide der Pflanze Chelidonium Majus und des Präparates Ukrain in einem Lymphom-Modell

Identifizierung Apoptose-induzierender Alkaloide der Pflanze Chelidonium Majus und des Präparates Ukrain in einem Lymphom-Modell